Biotech BioDlink Named “Emerging CDMO of the Year” at the 2026 Asia-Pacific Biopharma Excellence Awards March 15, 2026
Biotech Curis to Report Fourth Quarter 2025 Financial and Operating Results and Host Conference Call and Webcast on March 19, 2026 March 14, 2026
Biotech GenScript Strengthens Transatlantic Biotech Infrastructure with European mRNA Hub March 13, 2026
Biotech LOTTE Biologics to Participate in DCAT Week 2026 in New York to Explore Global Partnership Opportunities March 10, 2026
Biotech U.S. FDA Approves TECVAYLI® in Combination with DARZALEX FASPRO® for Relapsed/Refractory Multiple Myeloma March 9, 2026
Biotech Aisa Pharma Announces Encouraging Results from Phase 2 RECONNOITER Trial of AISA-021 (Cilnidipine) in Patients with Systemic Sclerosis-Associated Raynaud’s Phenomenon March 8, 2026
Biotech Johnson & Johnson Announces U.S. FDA Approval of TECVAYLI® plus DARZALEX FASPRO® for Relapsed/Refractory Multiple Myeloma, Offering a Potential New Standard of Care as Early as Second Line March 7, 2026
Biotech Global Nanomedicine Market is Projected to Cross the USD 550 Billion Mark by 2034 as Advanced Drug Delivery Technologies Accelerate Adoption | DelveInsight March 6, 2026
Search
Biotech
March 15, 2026
March 14, 2026
March 13, 2026
March 12, 2026
March 11, 2026
March 10, 2026
March 9, 2026
March 8, 2026
March 7, 2026
March 6, 2026
